What is the cutoff for stage 2 kidney disease in terms of glomerular filtration rate (GFR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stage 2 Chronic Kidney Disease GFR Cutoff

Stage 2 chronic kidney disease is defined by a glomerular filtration rate (GFR) of 60-89 mL/min/1.73 m² with evidence of kidney damage. 1, 2

CKD Staging Based on GFR

  • Stage 1: GFR ≥90 mL/min/1.73 m² with evidence of kidney damage 2
  • Stage 2: GFR 60-89 mL/min/1.73 m² with evidence of kidney damage 1, 2
  • Stage 3: GFR 30-59 mL/min/1.73 m² (subdivided into 3a: 45-59 and 3b: 30-44) 1, 2
  • Stage 4: GFR 15-29 mL/min/1.73 m² 1, 2
  • Stage 5: GFR <15 mL/min/1.73 m² or dialysis 1, 2

Important Diagnostic Considerations

  • For both Stage 1 and Stage 2 CKD, evidence of kidney damage must be present in addition to the GFR criteria 2

  • Evidence of kidney damage includes: 2, 3

    • Albuminuria (urinary albumin-to-creatinine ratio ≥30 mg/g) 1
    • Proteinuria 2
    • Hematuria 2
    • Pathological abnormalities on kidney biopsy 2
    • Abnormalities in imaging tests 2
  • The kidney damage must be present for at least 3 months to differentiate CKD from acute kidney injury 2, 3

Clinical Implications of Stage 2 CKD

  • Even with mild GFR reduction (60-89 mL/min/1.73 m²), patients with evidence of kidney damage have increased cardiovascular risk 4
  • Patients with Stage 2 CKD should be evaluated and treated for dyslipidemia and other cardiovascular risk factors 1
  • Stage 2 CKD patients have a higher prevalence of multiple cardiovascular risk factors compared to those with normal kidney function (44.9% vs 34.7% have 2 or more risk factors) 4

Measurement Considerations

  • GFR is typically estimated using equations based on serum creatinine or cystatin C 5
  • The most commonly used equations are the MDRD (Modification of Diet in Renal Disease) and CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formulas 6
  • CKD-EPI equation is generally preferred as it can overcome constraints of other formulas, especially in patients with diabetes 6

Common Pitfalls and Caveats

  • Relying solely on GFR without evidence of kidney damage can lead to overdiagnosis, especially in elderly patients 1, 7
  • GFR physiologically decreases with age, and in adults older than 70 years, values below 60 mL/min/1.73 m² may be considered normal 7
  • Laboratory reports often don't provide specific numeric values for eGFR >60 mL/min/1.73 m², making it difficult to distinguish between normal kidney function and Stage 2 CKD without evidence of kidney damage 1
  • Restricting routine testing to patients at increased risk of CKD reduces false-positive results 1

Management Implications

  • Early detection of Stage 2 CKD allows for interventions that may slow progression to more advanced stages 2
  • Management should focus on treating underlying causes and modifiable risk factors 1
  • For patients with diabetes and Stage 2 CKD, glycemic and blood pressure control are essential 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Kidney Disease Diagnosis and Staging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chronic Kidney Disease.

Lancet (London, England), 2017

Research

Normal reference values for glomerular filtration rate: what do we really know?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.